Legal & General Group Plc bought a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 45,097 shares of the company’s stock, valued at approximately $4,531,000. Legal & General Group Plc owned 0.24% of Addus HomeCare as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently modified their holdings of the company. Royal Bank of Canada grew its position in shares of Addus HomeCare by 24.3% during the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after buying an additional 1,347 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Addus HomeCare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after acquiring an additional 2,952 shares during the period. Jane Street Group LLC boosted its stake in Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after acquiring an additional 8,780 shares during the period. Finally, Intech Investment Management LLC grew its holdings in shares of Addus HomeCare by 44.7% during the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock valued at $1,420,000 after purchasing an additional 4,439 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several analysts recently issued reports on the company. Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 9th. Royal Bank Of Canada increased their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Citizens Jmp reiterated a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Monday, May 18th. Citigroup reissued a “market outperform” rating on shares of Addus HomeCare in a report on Friday, July 24th. Finally, Barclays upped their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a research report on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $128.86.
Insider Buying and Selling at Addus HomeCare
In related news, insider Heather Dixon sold 288 shares of the company’s stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $93.77, for a total value of $27,005.76. Following the completion of the sale, the insider owned 44,371 shares of the company’s stock, valued at $4,160,668.67. This represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is currently owned by corporate insiders.
Addus HomeCare Stock Performance
Shares of NASDAQ ADUS opened at $118.69 on Friday. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $124.43. The company has a market cap of $2.22 billion, a PE ratio of 20.82, a P/E/G ratio of 1.58 and a beta of 0.86. The stock has a 50 day simple moving average of $113.57 and a 200-day simple moving average of $103.09. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%.The firm had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the previous year, the business earned $1.49 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. On average, equities research analysts forecast that Addus HomeCare Corporation will post 6.3 EPS for the current year.
Addus HomeCare Company Profile
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Featured Articles
- Five stocks we like better than Addus HomeCare
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUS – Free Report).
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
